• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于检测循环免疫复合物的C1q固相酶微测定法:其在人类乳腺癌中的应用

C1q solid-phase enzymatic microassay for detection of circulating immune complexes: its application in human breast cancer.

作者信息

Manzo C, Longo C, Bianchin A

出版信息

Tumori. 1982 Feb 28;68(1):47-52. doi: 10.1177/030089168206800108.

DOI:10.1177/030089168206800108
PMID:7041380
Abstract

Circulating immune complexes (CIC) were detected and quantitated in human breast cancer to monitor the efficiency of mastectomy. For this aim a microimmunoenzymatic test was set up, applying a solid-phase C1q. Features of this assay can be summarized as follows: ability to estimate as low as 10 ng of aggregated human IgG (delta IgG), good reproducibility and simplicity of execution, and small serum sample required. A group of women with breast cancer at different stages (TNM classification) was tested for CIC, and 31.75% were positive. Almost all patients submitted to surgery showed a reduction of this parameter thereafter. A parallel study was carried out in another group of women with benign breast disease, and a significant incidence of CIC was found.

摘要

在人类乳腺癌中检测并定量循环免疫复合物(CIC),以监测乳房切除术的效果。为此目的,建立了一种微免疫酶试验,应用固相C1q。该检测方法的特点可总结如下:能够检测低至10 ng的聚合人IgG(δIgG),具有良好的重复性和操作简便性,并且所需血清样本量小。对一组处于不同阶段(TNM分类)的乳腺癌女性进行了CIC检测,其中31.75%呈阳性。几乎所有接受手术的患者此后该参数都有所降低。在另一组患有良性乳腺疾病的女性中进行了平行研究,发现CIC的发生率很高。

相似文献

1
C1q solid-phase enzymatic microassay for detection of circulating immune complexes: its application in human breast cancer.用于检测循环免疫复合物的C1q固相酶微测定法:其在人类乳腺癌中的应用
Tumori. 1982 Feb 28;68(1):47-52. doi: 10.1177/030089168206800108.
2
Immune complexes of IgG1 and IgG3 subclasses in human breast cancer sera detected by monoclonal antibodies in an indirect immunoenzymatic assay.在间接免疫酶测定中,通过单克隆抗体检测人乳腺癌血清中IgG1和IgG3亚类的免疫复合物。
Oncology. 1983;40(6):395-9. doi: 10.1159/000225772.
3
Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.通过单克隆抗C1q ELISA系统检测含C1q的免疫复合物。
J Immunol Methods. 1987 Sep 24;102(2):149-56. doi: 10.1016/0022-1759(87)90071-8.
4
Circulating immune complex-like materials which bind to heat inactivated C1q interfere with the C1q solid phase assay for immune complexes.与热灭活C1q结合的循环免疫复合物样物质会干扰免疫复合物的C1q固相测定。
Tohoku J Exp Med. 1985 Aug;146(4):449-56. doi: 10.1620/tjem.146.449.
5
[Detection of circulating immune complexes by immunoenzyme assay with solid phase Clq].用固相 Clq 免疫酶法检测循环免疫复合物
Rev Med Chil. 1984 Jun;112(6):547-52.
6
Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients.循环免疫复合物在乳腺癌患者长期随访中的预后意义
Oncology. 1988;45(5):337-43. doi: 10.1159/000226636.
7
Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.采用鸡抗人C3和抗人C1q微酶联免疫吸附测定法检测循环免疫复合物。
J Immunol Methods. 1988 Oct 4;113(1):93-9. doi: 10.1016/0022-1759(88)90385-7.
8
[Clinical significance of circulating immune complexes in patients with metastatic breast cancer].[转移性乳腺癌患者循环免疫复合物的临床意义]
Klin Wochenschr. 1982 Dec 1;60(23):1465-72. doi: 10.1007/BF01720995.
9
Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.肝细胞癌或慢性肝炎患者血清及腹水中的循环免疫复合物。
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1986 Feb;19(1):34-45.
10
A new capillary tube agglutination-inhibition test for the detection of circulating immune complexes containing endogenously bound C1q.
Immunol Lett. 1981 Jun;3(2):107-13. doi: 10.1016/0165-2478(81)90060-2.

引用本文的文献

1
Evaluation of circulating immune complexes in lymphomas and leukemias using two different assays.使用两种不同检测方法对淋巴瘤和白血病患者循环免疫复合物的评估。
Cancer Immunol Immunother. 1985;20(1):80-4. doi: 10.1007/BF00199778.